Cereno Scientific releases Insights video season 2 episode 2 with Prof. Benza
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 2 of season 2 in the Insights Video Series is released. The video highlights drug candidate CS1, currently being evaluated in a Phase II study, and reasons why it is such an exciting drug candidate. Participating in the video is Prof. Raymond L. Benza, System Director of Pulmonary Hypertension at Mount Sinai Icahn School of Medicine, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s